-
公开(公告)号：US20240207358A1
公开(公告)日：2024-06-27
申请号：US18288244
申请日：2022-05-10
Applicant: University of Connecticut
Inventor： LIPING XIAO , Marja HURLEY , Tannin SCHMIDT
CPC classification number: A61K38/1709 , A61P7/06
Abstract: The present disclosure is directed to administration of native or recombinant human PRG4 (rhPRG4) as a means to treat sickle cell disease or other disorders in subjects in need of treatment thereof.
Search Results
1
records
(took 0.013 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
